Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force

BACKGROUND: Neuroblastoma is an embryonic tumour of the sympathetic nervous system, metastatic in half of the patients at diagnosis, with a high preponderance of osteomedullary disease, making accurate evaluation of metastatic sites and response to therapy challenging. Metaiodobenzylguanidine (mIBG)...

Descripción completa

Detalles Bibliográficos
Autores principales: Matthay, K K, Shulkin, B, Ladenstein, R, Michon, J, Giammarile, F, Lewington, V, Pearson, A D J, Cohn, S L
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2010
Materias:
Guidelines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2865749/
https://www.ncbi.nlm.nih.gov/pubmed/20424613
http://dx.doi.org/10.1038/sj.bjc.6605621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2865749/
https://www.ncbi.nlm.nih.gov/pubmed/20424613
http://dx.doi.org/10.1038/sj.bjc.6605621

Ejemplares similares